Search Results
Search for other papers by Qi Zhang in
Google Scholar
PubMed
Search for other papers by Hongshan Wang in
Google Scholar
PubMed
Search for other papers by Yanhong Xie in
Google Scholar
PubMed
Search for other papers by Suming Huang in
Google Scholar
PubMed
Search for other papers by Ke Chen in
Google Scholar
PubMed
Search for other papers by Botian Ye in
Google Scholar
PubMed
Search for other papers by Yupeng Yang in
Google Scholar
PubMed
Search for other papers by Jie Sun in
Google Scholar
PubMed
Search for other papers by Hongyong He in
Google Scholar
PubMed
Search for other papers by Fenglin Liu in
Google Scholar
PubMed
Search for other papers by Zhenbin Shen in
Google Scholar
PubMed
Search for other papers by Weidong Chen in
Google Scholar
PubMed
Search for other papers by Kuntang Shen in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Yihong Sun in
Google Scholar
PubMed
activity ( 1 ). The prognosis of high-grade GEP-NENs, also known as grade 3 GEP-NENs, was much worse than that of grade 1 neuroendocrine tumors (G1 NET) and grade 2 neuroendocrine tumors (G2 NET) ( 2 , 3 , 4 ). However, the 2010 WHO classification was
Search for other papers by Peiwen Wu in
Google Scholar
PubMed
Search for other papers by Dongjie He in
Google Scholar
PubMed
Search for other papers by Hao Chang in
Google Scholar
PubMed
Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed
according to SEER records and previous reports ( 4 ). The tumors were classified as localized, regional, or distant. For tumor classification, the SEER classification scheme was used to systematically categorize cases into four grades, namely, G1, G2, G3
Search for other papers by Hanbaro Kim in
Google Scholar
PubMed
Search for other papers by Ki Byung Song in
Google Scholar
PubMed
Search for other papers by Dae Wook Hwang in
Google Scholar
PubMed
Search for other papers by Jae Hoon Lee in
Google Scholar
PubMed
Search for other papers by Shadi Alshammary in
Google Scholar
PubMed
Search for other papers by Song Cheol Kim in
Google Scholar
PubMed
.1%) patients, LVi was identified in 122 (22.5%) patients. Thirty-one (5.7%) patients had a positive resection margin. Figure 3 Evolving trend in clinicopathological features of surgically resected pancreatic neuroendocrine tumors (PNETs) during the study
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Xuefeng Xu in
Google Scholar
PubMed
Search for other papers by Hongyun Ma in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Dansong Wang in
Google Scholar
PubMed
Search for other papers by Tiantao Kuang in
Google Scholar
PubMed
Search for other papers by Wenchuan Wu in
Google Scholar
PubMed
Search for other papers by Bin Song in
Google Scholar
PubMed
Search for other papers by Gang Li in
Google Scholar
PubMed
Search for other papers by Gang Jin in
Google Scholar
PubMed
Search for other papers by Wenhui Lou in
Google Scholar
PubMed
Z Tang LH Hruban RH Adsay V McCall CM Krasinskas AM Jang KT Frankel WL Balci S , et al . The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and
Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Search for other papers by Johan Botling in
Google Scholar
PubMed
Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Search for other papers by Barbro Eriksson in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Search for other papers by Anders Sundin in
Google Scholar
PubMed
Search for other papers by Joakim Crona in
Google Scholar
PubMed
grading of panNENs ( 3 ), high-grade neoplasms were separated into two categories: well-differentiated (WD) pancreatic neuroendocrine tumor grade 3 (panNET-G3) and poorly differentiated (PD) NEC ( 4 ). PanNET-G3 frequently harbors mutations in MEN1 and
Search for other papers by Yang Lv in
Google Scholar
PubMed
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Chunyan Zhang in
Google Scholar
PubMed
Search for other papers by Yuan Fang in
Google Scholar
PubMed
Search for other papers by Ning Pu in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Dansong Wang in
Google Scholar
PubMed
Search for other papers by Xu Xuefeng in
Google Scholar
PubMed
Search for other papers by Wenhui Lou in
Google Scholar
PubMed
-proliferative ability (including Ki-67 proliferation index and mitotic rate) to divide NETs into three pathological grades: G1, G2 and G3. Of these, the G3 NF-pancreatic neuroendocrine carcinomas (NECs) are defined as a tumor with Ki-67 proliferation index greater than
Search for other papers by Roxanne C S van Adrichem in
Google Scholar
PubMed
Search for other papers by Aart Jan van der Lely in
Google Scholar
PubMed
Search for other papers by Martin Huisman in
Google Scholar
PubMed
Search for other papers by Piet Kramer in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Patric J D Delhanty in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
neuroendocrine tumors (NETs), and the distribution of plasma acylated ghrelin (AG), plasma unacylated ghrelin (UAG), and acylated ghrelin/unacylated ghrelin (AG/UAG) ratio. Data are expressed as median±interquartile range (IQR). In Fig. 3A , tumor
Search for other papers by Irvin M Modlin in
Google Scholar
PubMed
Search for other papers by Harry Aslanian in
Google Scholar
PubMed
Wren Laboratories, Yale University School of Medicine, 35 NE Industrial Road, Branford, Connecticut, USA
Search for other papers by Lisa Bodei in
Google Scholar
PubMed
Search for other papers by Ignat Drozdov in
Google Scholar
PubMed
Search for other papers by Mark Kidd in
Google Scholar
PubMed
)). Mean age 56.7 (range 25–82 years), gender: 40 males to 85 females, n =125. Tumor distribution No. Grade Stage Treatment Current PPIs G1 G2 G3 Local Distant Untreated Current SSAs Gastric 3 0 1 2 3 0 3 0 0 Duodenum 1 1 0 0
Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Search for other papers by Dong Cen in
Google Scholar
PubMed
Search for other papers by Hui Liu in
Google Scholar
PubMed
Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Search for other papers by Zhe Wan in
Google Scholar
PubMed
Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Search for other papers by Zhongjie Lin in
Google Scholar
PubMed
Search for other papers by Yanting Wang in
Google Scholar
PubMed
Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Search for other papers by Junjie Xu in
Google Scholar
PubMed
Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Search for other papers by Yuelong Liang in
Google Scholar
PubMed
that the 1-, 2-, 3- and 4-year survival rates were 43–45, 30–33, 28–31, and 22–26%, respectively ( 7 ). In a study of biliary neuroendocrine neoplasms, the median survival of GB-NEN patients was 7.9 months and only grade 3 tumors, according to the 2010
Search for other papers by R C S van Adrichem in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
Search for other papers by M C De Martino in
Google Scholar
PubMed
Search for other papers by P M van Koetsveld in
Google Scholar
PubMed
Search for other papers by C H J van Eijck in
Google Scholar
PubMed
Search for other papers by R R de Krijger in
Google Scholar
PubMed
Search for other papers by D M Sprij-Mooij in
Google Scholar
PubMed
Search for other papers by J A M J L Janssen in
Google Scholar
PubMed
Search for other papers by W W de Herder in
Google Scholar
PubMed
studies have shown a significant shorter survival in Grade 3 GEP NET patients (Ki-67 index >20%) (24, 25) . A possible explanation for our discrepant results could be the very small sample size of these heterogeneous tumor entities and the short follow